These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1347773)
1. The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer. Yamanaka Y Nihon Ika Daigaku Zasshi; 1992 Feb; 59(1):51-61. PubMed ID: 1347773 [TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical study on epidermal growth factor and its receptor in human pancreatic carcinoma]. Yamanaka Y; Onda M; Uchida E; Kobayashi T; Sasajima K; Tokunaga A; Tajiri T; Egami K; Asano G Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1544-50. PubMed ID: 2214281 [TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factors and apoptosis markers in pancreatic ductal adenocarcinoma. Pryczynicz A; Guzińska-Ustymowicz K; Czyzewska J; Kemona A Folia Histochem Cytobiol; 2009; 47(4):667-71. PubMed ID: 20430737 [TBL] [Abstract][Full Text] [Related]
4. The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma. Ueda S; Ogata S; Tsuda H; Kawarabayashi N; Kimura M; Sugiura Y; Tamai S; Matsubara O; Hatsuse K; Mochizuki H Pancreas; 2004 Jul; 29(1):e1-8. PubMed ID: 15211117 [TBL] [Abstract][Full Text] [Related]
5. Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma. Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J Anticancer Res; 2008; 28(2B):1399-404. PubMed ID: 18505086 [TBL] [Abstract][Full Text] [Related]
6. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach. Czyzewska J; Guzinska-Ustymowicz K; Kemona A Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients]. Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T Gan To Kagaku Ryoho; 1991 Jun; 18(7):1181-5. PubMed ID: 1675844 [TBL] [Abstract][Full Text] [Related]
8. Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma. Zhang L; Yuan SZ Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):620-3. PubMed ID: 14607699 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters. Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491 [TBL] [Abstract][Full Text] [Related]
10. The erbB-3 gene in human pancreatic cancer. Lemoine NR; Lobresco M; Leung H; Barton C; Hughes CM; Prigent SA; Gullick WJ; Klöppel G J Pathol; 1992 Nov; 168(3):269-73. PubMed ID: 1361525 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: evidence for a cyclin D1-dependent cell cycle progression. Poch B; Gansauge F; Schwarz A; Seufferlein T; Schnelldorfer T; Ramadani M; Beger HG; Gansauge S Pancreas; 2001 Oct; 23(3):280-7. PubMed ID: 11590324 [TBL] [Abstract][Full Text] [Related]
12. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways. Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713 [TBL] [Abstract][Full Text] [Related]
13. ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer. Graber HU; Friess H; Kaufmann B; Willi D; Zimmermann A; Korc M; Büchler MW Int J Cancer; 1999 Feb; 84(1):24-7. PubMed ID: 9988227 [TBL] [Abstract][Full Text] [Related]
14. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit. Kommoss F; Colley M; Hart CE; Franklin WA Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111 [TBL] [Abstract][Full Text] [Related]
15. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues. Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients. Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. Tokunaga A; Onda M; Okuda T; Teramoto T; Fujita I; Mizutani T; Kiyama T; Yoshiyuki T; Nishi K; Matsukura N Cancer; 1995 Mar; 75(6 Suppl):1418-25. PubMed ID: 7889468 [TBL] [Abstract][Full Text] [Related]
18. Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis. Friess H; Yamanaka Y; Büchler M; Kobrin MS; Tahara E; Korc M Int J Cancer; 1994 Mar; 56(5):668-74. PubMed ID: 8314343 [TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor and its receptors in human pancreatic carcinoma. Chen YF; Pan GZ; Hou X; Liu TH; Chen J; Yanaihara C; Yanaihara N Pancreas; 1990 May; 5(3):278-83. PubMed ID: 2343041 [TBL] [Abstract][Full Text] [Related]
20. Expression of ERRP in normal and neoplastic pancreata and its relationship to clinicopathologic parameters in pancreatic adenocarcinoma. Feng J; Adsay NV; Kruger M; Ellis KL; Nagothu K; Majumdar AP; Sarkar FH Pancreas; 2002 Nov; 25(4):342-9. PubMed ID: 12409827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]